Migraine Drugs Market Value Expected to Grow $ 2,190 Mn by 2025 : Allied Market Research

"The growing awareness of the worldwide treatment and prevention of migraine is expected to accelerate the growth of the migraine treatment market. And the increase in the worldwide female population is a key factor in promoting market growth."

A new report "Migraine Drugs by Type, Route of Administration, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025" published by Allied Market Research. The market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811

Migraine is characterized by a recurrent tingling headache that affects only one side of the head. In some cases, there is vomiting, nausea, and visual disturbances.

The increase in the prevalence of migraine, the rapid increase in the female population, and the increased awareness of patients for the treatment and prevention of migraines are driving the growth of the worldwide migraine treatment market. However, the side effects of migraine treatment are expected to limit market growth. Conversely, new therapies / drugs for migraine treatment and growth opportunities emerge in emerging markets.

By type, there are illegal drugs in 2017 that account for more than three-quarters of the world's migraine drug market share. Depending on the route of administration, the oral market is expected to grow at a rate of 3.4% over the forecast period.

Key Findings of the Migraine Drugs Market:

• North America occupied two-fifths share of the global migraine drugs market.
• Oral is anticipated to grow with the highest CAGR throughout the forecast period.
• Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811

The report provides an extensive competitive analysis and profiles of the key market players such as Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc. The other players in the value chain (not included in the report) include Novartis International AG, Teva Pharmaceutical Industries Limited, and Sanofi SA.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.